Edmond DE Rothschild Holding S.A. Has $102.86 Million Holdings in CVS Health Co. (NYSE:CVS)

Edmond DE Rothschild Holding S.A. reduced its position in shares of CVS Health Co. (NYSE:CVSFree Report) by 4.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,302,620 shares of the pharmacy operator’s stock after selling 54,738 shares during the quarter. CVS Health accounts for about 1.9% of Edmond DE Rothschild Holding S.A.’s investment portfolio, making the stock its 10th biggest holding. Edmond DE Rothschild Holding S.A. owned 0.10% of CVS Health worth $102,855,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CVS. SOA Wealth Advisors LLC. grew its holdings in CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 133 shares in the last quarter. Apella Capital LLC lifted its position in shares of CVS Health by 4.2% during the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after buying an additional 136 shares during the last quarter. Prairie Sky Financial Group LLC lifted its position in shares of CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after buying an additional 141 shares during the last quarter. WealthShield Partners LLC lifted its position in shares of CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after buying an additional 141 shares during the last quarter. Finally, Sugarloaf Wealth Management LLC lifted its position in shares of CVS Health by 9.5% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock valued at $129,000 after buying an additional 142 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.24% of the stock is owned by corporate insiders.

CVS Health Stock Performance

Shares of NYSE CVS traded down $0.11 during midday trading on Monday, reaching $55.54. 11,725,700 shares of the stock were exchanged, compared to its average volume of 12,009,923. The firm has a market cap of $69.72 billion, a price-to-earnings ratio of 9.76, a PEG ratio of 0.53 and a beta of 0.56. CVS Health Co. has a twelve month low of $53.70 and a twelve month high of $83.25. The firm has a 50-day simple moving average of $67.13 and a two-hundred day simple moving average of $71.94. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.20 EPS. As a group, analysts anticipate that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.79%. CVS Health’s payout ratio is 46.75%.

Analyst Ratings Changes

CVS has been the subject of several analyst reports. Wells Fargo & Company decreased their price target on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 7th. TD Cowen lowered shares of CVS Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $99.00 to $59.00 in a research report on Tuesday, May 7th. The Goldman Sachs Group decreased their price objective on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Barclays decreased their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a research report on Thursday, May 2nd. Finally, SVB Leerink reaffirmed a “market perform” rating and issued a $60.00 price objective (down from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Nine investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $76.75.

View Our Latest Research Report on CVS

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.